SEC CIK 1900910
Shah Prem S
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| CVSview stock → | 64,356.099 | 2026-04-01 |
Position History — CVS
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — CVS
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-04-01 | Tax withholding | 1,484 | $72.49 | 64,356.099 |
| 2026-03-31 | Grant / award (derivative) | 161,676 | $71.82 | 161,676 |
| 2026-03-31 | Grant / award | 25,062 | $71.82 | 62,852 |
| 2026-01-01 | Tax withholding | 247 | $80.13 | 61,509.324 |
| 2025-08-31 | Tax withholding | 6,995 | $73.15 | 60,631.68 |
| 2025-04-01 | Grant / award (derivative) | 112,289 | $67.98 | 112,289 |
| 2025-04-01 | Tax withholding | 1,308 | $67.98 | 47,250.68 |
| 2025-04-01 | Grant / award | 26,478 | $67.98 | 58,166 |
| 2025-03-17 | Option exercise (derivative) | 846 | $0.00 | 0 |
| 2025-03-17 | Option exercise | 846 | $62.21 | 43,189.68 |
| 2024-11-30 | Grant / award (derivative) | 746,268 | $71.82 | 746,268 |
| 2024-04-01 | Grant / award (derivative) | 62,695 | $79.56 | 62,695 |
| 2024-04-01 | Tax withholding | 2,653 | $79.56 | 47,273.46 |
| 2024-04-01 | Grant / award | 15,082 | $0.00 | 37,057 |
| 2024-04-01 | Tax withholding | 5,239 | $79.56 | 42,034.46 |
| 2024-02-26 | Tax withholding | 261 | $76.43 | 43,185.46 |
| 2024-02-16 | Open-market sale | 29,473 | $76.95 | 39,764.76 |
| 2024-02-12 | Grant / award | 13,313 | $0.00 | 69,237.76 |
| 2023-08-31 | Tax withholding | 3,508 | $65.17 | 50,987.72 |
| 2023-04-01 | Grant / award (derivative) | 89,073 | $74.31 | 89,073 |
| 2023-04-01 | Tax withholding | 3,221 | $74.31 | 49,364.32 |
| 2023-02-27 | Tax withholding | 226 | $85.77 | 44,403.32 |
| 2022-08-31 | Grant / award | 20,376 | $0.00 | 20,376 |
| 2022-05-31 | Grant / award | 20,671 | $0.00 | 20,671 |
| 2022-05-31 | Grant / award | 0 | $0.00 | 0 |
| 2022-04-08 | Option exercise (derivative) | 4,103 | $0.00 | 28,723 |
| 2022-04-08 | Option exercise (derivative) | 3,157 | $0.00 | 9,469 |
| 2022-04-08 | Option exercise (derivative) | 845 | $0.00 | 846 |
| 2022-04-08 | Option exercise (derivative) | 5,719 | $0.00 | 28,596 |
| 2022-04-08 | Option exercise | 4,103 | $74.30 | 50,686.24 |
| 2022-04-08 | Option exercise | 5,719 | $58.34 | 52,302.24 |
| 2022-04-08 | Option exercise | 845 | $62.21 | 47,428.24 |
| 2022-04-08 | Open-market sale | 4,103 | $105.00 | 46,583.24 |
| 2022-04-08 | Open-market sale | 3,130 | $105.00 | 43,453.24 |
| 2022-04-08 | Option exercise | 3,157 | $54.19 | 49,740.24 |
| 2022-04-01 | Grant / award (derivative) | 41,580 | $101.09 | 41,580 |
| 2022-04-01 | Tax withholding | 18,747 | $101.09 | 40,324.24 |
| 2022-04-01 | Tax withholding | 3,731 | $101.09 | 46,583.24 |
| 2022-03-30 | Option exercise (derivative) | 5,346 | $0.00 | 0 |
| 2022-03-30 | Open-market sale | 5,346 | $104.70 | 59,071.24 |
| 2022-03-30 | Option exercise | 5,346 | $102.26 | 64,417.24 |
| 2022-03-17 | Option exercise (derivative) | 2,935 | $0.00 | 2,935 |
| 2022-03-17 | Open-market sale | 1,689 | $106.65 | 59,071.24 |
| 2022-03-17 | Option exercise | 2,935 | $104.82 | 62,006.24 |
| 2022-02-28 | Tax withholding | 141 | $103.65 | 60,760.24 |
| 2022-02-26 | Tax withholding | 226 | $104.30 | 59,394.24 |
| 2022-02-21 | Grant / award | 47,640 | $0.00 | 59,620.24 |
| 2022-01-01 | — | — | — | 11,980.24 |
| 2022-01-01 | — | — | — | 575 |
| 2022-01-01 | — | — | — | 2,884 |
| 2022-01-01 | — | — | — | 15,427 |
| 2022-01-01 | — | — | — | 1,808 |
| 2022-01-01 | — | — | — | 1,925 |
| 2022-01-01 | — | — | — | 6,393 |
| 2022-01-01 | — | — | — | 4,372.62 |
| 2022-01-01 | — | — | — | 2,798 |
| 2022-01-01 | — | — | — | 5,625.28 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.